HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 111 | 115 | 96.5% | |
| HF004 | 2020 | 114 | 122 | 93.4% | |
| HF006 | 2021 | 150 | 157 | 95.5% | |
| HF006 | 2022 | 162 | 169 | 95.9% | |
| HF006 | 2023 | 185 | 192 | 96.4% |
